(certain client names and engagements cannot be disclosed due to confidentiality obligations)
Strategic Advisory & Market Entry
Delivered roadmap for a pharma division of a European corporation for Japan launch of novel asset for cardiac diagnostic.
Supported the executive team of a European biotech venture in developing strategy and roadmap to validate and commercialize novel drug candidate for cancer.
Orchestrated a partnership among companies in Japan, Europe, and the US, for Chugai Pharmaceutical to develop a commercial digital care solution for patients and healthcare professionals.
Served as the Japan Business Lead for Servier pharma digital business unit, driving business development for novel medical devices and diagnostic software.
Identified and facilitated clinical and commercial partnerships in Japan for Bioserenity, a European EEG devices and diagnostics software company.
Technology Scouting & Open Innovation
Cultivated innovation networks across Japan and Singapore to source and evaluate emerging technologies for a global pharma company.
Sourced blood biomarkers for point-of-care diagnostics device manufacturer for a New Business Development of a Japanese international group.
Assessed blockchain applications and tangible value creation opportunities across the pharmaceutical value chain.
Designed and delivered workshops for international pharma teams on practical approaches to mapping and assessing digital transformation opportunities.
Digital Health & Solution Delivery
Supported the development and commercialization of digital health solutions, including digital biomarkers and patient-facing care platforms.
Implemented custom digital solutions, including ePRO mobile applications, to support clinical studies.
Integrated IoT and wearable technologies into personalized healthcare and patient monitoring solutions.
Delivered a strategic plan and implementation roadmap for secure data architecture and integration for a Japanese digital health company in dementia and Alzheimer’s disease.
Automated data workflows and analytics pipelines to support pharma business intelligence and executive decision-making.
cardiology
oncology
diabetes
neurodegenerative
hemophilia
endometriosis & women's health